Georgia

Reimbursed Care Access

In the U.S. state of Georgia, classic serotonergic and empathogenic psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, ibogaine, 2C‑X and ayahuasca/DMT‑containing brews) are controlled and carry no routine medical/reimbursement pathway outside of authorized research. Esketamine (Spravato®) is an FDA‑approved, REMS‑restricted treatment available in certified clinics and is variably reimbursed by commercial insurers, Medicare, and some Medicaid managed plans in Georgia; racemic or S‑ketamine used off‑label (IV ketamine) is widely available in private clinics but generally lacks standardized insurance reimbursement.